COLOPLAST A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 863.4 DKK | -0.09% |
|
-3.66% | +11.84% |
| Feb. 27 | Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. | CI |
| Feb. 14 | COLOPLAST : Q1 24: Many more positives beyond the margin beat |  |
Presenter SpeechEllen Bjurgert (Executives)Right. I'd like to welcome you most warmly to this ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
2024-05-07
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
863.4
DKK
Average target price
917.1
DKK
Spread / Average Target
+6.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.84% | 27.91B | |
| -32.98% | 2.95B | |
| -15.97% | 2.47B | |
| +11.90% | 2.22B | |
| -1.11% | 1.91B | |
| -13.37% | 1.84B | |
| -7.78% | 1.4B | |
| -0.38% | 1.26B | |
| +13.51% | 1.13B | |
| +4.01% | 1.13B |
- Stock Market
- Equities
- COLO B Stock
- News Coloplast A/S
- Transcript : Coloplast A/S - Shareholder/Analyst Call
